Hemolytic Disease

Hemolytic disease of the newborn known as hemolytic disease of the fetus and newborn or erythroblastosis fetalis, is an alloimmune condition that establish in a fetus when the IgG molecules produced by the mother pass through the placenta. Among these antibodies are some which invasion antigens on the red blood cells in the fetal circulation, breaking down and destroying the cells. The fetus can establish reticulocytosis and anemia. This fetal disease ranges from mild to very severe, and fetal death from heart failure can exist. When the disease is moderate or severe, many erythroblasts are present in the fetal blood, and so these forms of the disease can be called erythroblastosis fetalis

  • Hemolytic Anemia/Diagnosis
  • Immunoglobulin Transfusion in Hemolytic Disease
  • Neurology of the New born
  • Intravascular Hemolysis
  • Immune Tolerance of Pregnancy
  • Pediatric Breast Disorder

Related Conference of Hemolytic Disease

June 11-12, 2024

31st Global Nursing and Health Care Conference

Amsterdam, Netherlands
June 20-21, 2024

55th World Nursing and Healthcare Conference

Dublin, Ireland
June 27-28, 2024

61st World Nursing Conference

London, UK
July 18-19, 2024

31st Global Nursing and Healthcare Congress

Paris, France
August 08-09, 2024

43rd World Nursing and Healthcare Conference

London, UK
September 04-05, 2024

World Nursing Congress

Toronto, Canada
October 10-11, 2024

16th International Conference on Gynecology

Madrid, Spain
December 04-05, 2024

4th Global Summit on Nursing Practice

Orlando, USA

Hemolytic Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in